| temozolomide / Generic mfg. |
NCT00034697: Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) |
|
|
| Terminated | 2 | 24 | NA | temozolomide | Merck Sharp & Dohme LLC | Metastases, Neoplasm, Carcinoma, Non-Small-Cell Lung, Brain Neoplasms | 01/03 | 01/03 | | |
NCT00076856: Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) |
|
|
| Completed | 2 | 95 | NA | Temozolomide | Merck Sharp & Dohme LLC | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Brain Neoplasms | 03/06 | 03/06 | | |
NCT00831545: Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) |
|
|
| Completed | 2 | 162 | NA | Temozolomide, SCH 52365 | Merck Sharp & Dohme LLC, Quintiles, Inc. | Metastases of Central Nervous System, Melanoma, Breast Neoplasm, Carcinoma, Non-Small-Cell Lung | 10/06 | 10/06 | | |
NCT00266812 / 2004-001749-13: Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED) |
|
|
| Terminated | 2 | 35 | NA | Temozolomide and radiotherapy, Temodal, TMZ, SCH 052365, Whole brain radiotherapy | Merck Sharp & Dohme LLC, AESCA Pharma GmbH | Carcinoma, Non-Small-Cell Lung | 01/08 | 01/08 | | |
NCT00582075: Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases |
|
|
| Completed | 2 | 25 | US | temozolomide, Temodar | University of Alabama at Birmingham, Integrated Therapeutics Group | Cancer, Brain Metastases | 10/08 | 06/15 | | |
NCT00385398: QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC |
|
|
| Withdrawn | 2 | 0 | US | erlotinib hydrochloride, temozolomide, stereotactic radiosurgery | University of Medicine and Dentistry of New Jersey, National Cancer Institute (NCI), Schering-Plough, Genentech, Inc. | Lung Cancer, Metastatic Cancer | 12/08 | 12/08 | | |
| Terminated | 2 | 6 | NA | temozolomide | Merck Sharp & Dohme LLC | Breast Neoplasm, Brain Neoplasm, Second Neoplasm | 06/10 | 06/10 | | |
NCT01867619: Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients |
|
|
| Withdrawn | 2 | 0 | US | Lomustine, CCNU, CeeNU, Temozolomide, Temodar, Thalidomide, Thalomid | M.D. Anderson Cancer Center, Celgene Corporation | Brain Neoplasms, Melanoma | 02/12 | | | |
NCT01400958: Nuvigil or Placebo in Newly Diagnosed Malignant Glioma |
|
|
| Terminated | 2 | 6 | US | Nuvigil®, Armodafinil, Placebo | H. Lee Moffitt Cancer Center and Research Institute, Cephalon | Malignant Glioma | 12/12 | 09/13 | | |
